Mylan Laboratories

Mylan is a global pharmaceutical company with market leading positions in generic pharmaceuticals, transdermal technology and unit dose packaged products. We focus on providing an extensive line of affordable, high quality prescription drugs in traditional and innovative dosage forms, and we enjoy a well-deserved reputation for scientific expertise in creating difficult-to-formulate and high-barrier-to-entry generic products. Mylan operates three principal subsidiaries, Mylan Pharmaceuticals Inc., Mylan Technologies Inc. and UDL Laboratories Inc. (all wholly-owned), and has a 71.5% controlling interest in Matrix Laboratories Limited (71.5% owned). Mylan Pharmaceuticals Inc., with locations in Morgantown, W.Va., Caguas, Puerto Rico, and Greensboro, N.C., is a world leader in the research, development, production and marketing of generic pharmaceuticals. Mylan Technologies Inc., located in St. Albans and Swanton, Vt., is a leader in transdermal drug delivery technology and is the largest producer of generic and branded transdermal patches for the U.S. market. UDL Laboratories Inc., with locations in Rockford, Ill., and Sugar Land, Texas, is the top U.S.-supplier of unit dose pharmaceuticals to hospitals and other institutions. Mylan also owns a controlling interest in India-based Matrix Laboratories Limited, which provides Mylan with a platform for global expansion and growth. Matrix is the second largest supplier of active pharmaceutical ingredient (API) sourcing and provides expanded marketing capabilities through Docpharma, a Matrix subsidiary that is a primary marketer of branded generics in Europe. Matrix is a public limited company listed on the Bombay Stock Exchange and the National Stock Exchange of India and currently owns, in whole or in part, 12 other facilities and business units located in India, China and South Africa.

Contact Details: 1500 Corporate Drive Suite 400 Canonsburg PA 15317 United States of America Tel: 724-514-1800 Fax: Email: investor_relations@mylan.com WWW: www.mylan.com/

Loading...

Press Releases on Mylan Laboratories:
Digirad Names Two Veteran Healthcare Executives to Board	20th May, 2009	Digirad Corporation	Steven C. Mendell and Lloyd H. Malchow Join Digirad Board of Directors POWAY, Calif., May 20 /PRNewswire-FirstCall/ -- Digirad Corporation (Nasdaq:
Halo Pharmaceutical Welcomes Dr. George Bobotas as Its Chief Scientific Officer	20th April, 2009	Halo Pharmaceutical	WHIPPANY, N.J., April 20 /PRNewswire/ -- As part of a Research and Development partnership between Halo Pharmaceutical and DeMelleBioPharma, LLC, Dr. George Bobotas joins Halo Pharmaceutical as
Valeant Pharmaceuticals Appoints President of Valeant Pharmaceuticals International	19th March, 2009	Valeant Pharmaceuticals International	ALISO VIEJO, Calif., March 19 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals (NYSE: VRX) today announced that it has appointed Dr. Bhaskar Chaudhuri to the position of President, Valeant
USPTO Confirms Validity of Bystolic(R) Patent	24th November, 2008	Forest Laboratories, Inc.	NEW YORK, Nov. 24, 2008 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE: FRX) announced today that the U.S. Patent and Trademark Office ("USPTO") has closed prosecution on the

BioNews Results for Mylan Laboratories:
Matrix Labs turns corner, net profit at Rs 30 cr in FY'09	PharmaBiz:  Jun 27 2009 8:43AM Matching: mylan laboratories
Roche stops selling acne drug Accutane	Forbes.com:  Jun 26 2009 9:25PM Matching: mylan laboratories
UPDATE 3-Roche stops selling acne drug Accutane	Forbes.com:  Jun 26 2009 10:02PM Matching: mylan laboratories
UPDATE 3-Roche stops selling acne drug Accutane	FinanzNachrichten.de:  Jun 26 2009 9:01PM Matching: mylan laboratories
UPDATE 3-Roche stops selling acne drug Accutane	Interactive Investor International:  Jun 26 2009 8:54PM Matching: mylan laboratories
Promote your company here: BioNewsCast - Press Release Distribution	→View more Mylan Laboratories news.

Mylan Laboratories (MYL) Financial information Links from Barchart
MYL Quote from from Barchart.com
MYL Chart from from Barchart.com
MYL Profile from from Barchart.com
MYL Opinion from from Barchart.com
→View more Mylan Laboratories finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 2944 times since April 2007, the link to the organisation's website has been followed 345 times

Recent Search Terms used to find this page: mylan laboratories matrix | mylan laboratories Dr TEL | t | mylan laboratories in puerto rico | who owns mylan laboratories | Mylan Laboratories | mylan pharmaceuticals Puerto Rico | Mylan Laboratories sugarland | Mylan Lab | Mylan Lab | .

Search for more companies in Canonsburg

Search for more companies in PA

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Mylan Laboratories